Cargando…

IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells

Glioblastoma multiforme (GBM) is a notably lethal brain tumor associated with high proliferation rate and therapeutic resistance, while currently effective treatment options are still lacking. Imidazo[1,2-a]pyridine derivatives and organoselenium compounds are largely used in medicinal chemistry and...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Daniela C., Rafique, Jamal, Saba, Sumbal, Grinevicius, Valdelúcia M. A. S., Filho, Danilo W., Zamoner, Ariane, Braga, Antonio L., Pedrosa, Rozangela C., Ourique, Fabiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964227/
https://www.ncbi.nlm.nih.gov/pubmed/35360199
http://dx.doi.org/10.1155/2022/3710449
_version_ 1784678165974614016
author dos Santos, Daniela C.
Rafique, Jamal
Saba, Sumbal
Grinevicius, Valdelúcia M. A. S.
Filho, Danilo W.
Zamoner, Ariane
Braga, Antonio L.
Pedrosa, Rozangela C.
Ourique, Fabiana
author_facet dos Santos, Daniela C.
Rafique, Jamal
Saba, Sumbal
Grinevicius, Valdelúcia M. A. S.
Filho, Danilo W.
Zamoner, Ariane
Braga, Antonio L.
Pedrosa, Rozangela C.
Ourique, Fabiana
author_sort dos Santos, Daniela C.
collection PubMed
description Glioblastoma multiforme (GBM) is a notably lethal brain tumor associated with high proliferation rate and therapeutic resistance, while currently effective treatment options are still lacking. Imidazo[1,2-a]pyridine derivatives and organoselenium compounds are largely used in medicinal chemistry and drug development. This study is aimed at further investigating the antitumor mechanism of IP-Se-06 (3-((2-methoxyphenyl)selanyl)-7-methyl-2-phenylimidazol[1,2-a]pyridine), a selenylated imidazo[1,2-a]pyridine derivative in glioblastoma cells. IP-Se-06 exhibited high cytotoxicity against A172 cells (IC(50) = 1.8 μM) and selectivity for this glioblastoma cell. The IP-Se-06 compound has pharmacological properties verified in its ADMET profile, especially related to blood-brain barrier (BBB) permeability. At low concentration (1 μM), IP-Se-06 induced intracellular redox state modulation with depletion of TrxR and GSH levels as well as inhibition of NRF2 protein. IP-Se-06 also decreased mitochondrial membrane potential, induced cytochrome c release, and chromatin condensation. Furthermore, IP-Se-06 induced apoptosis by decreasing levels of Bcl-xL while increasing levels of γ-H2AX and p53 proteins. Treatment with IP-Se-06 induced cell cycle arrest and showed antiproliferative effect by inhibition of Akt/mTOR/HIF-1α and ERK 1/2 signaling pathways. In addition, IP-Se-06 displayed significant inhibition of p38 MAPK and p-p38, leading to inhibition of inflammasome complex proteins (NLRP3 and caspase-1) in glioblastoma cells. These collective findings demonstrated that IP-Se-06 is a bioactive molecule that can be considered a candidate for the development of a novel drug for glioblastoma treatment.
format Online
Article
Text
id pubmed-8964227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89642272022-03-30 IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells dos Santos, Daniela C. Rafique, Jamal Saba, Sumbal Grinevicius, Valdelúcia M. A. S. Filho, Danilo W. Zamoner, Ariane Braga, Antonio L. Pedrosa, Rozangela C. Ourique, Fabiana Oxid Med Cell Longev Research Article Glioblastoma multiforme (GBM) is a notably lethal brain tumor associated with high proliferation rate and therapeutic resistance, while currently effective treatment options are still lacking. Imidazo[1,2-a]pyridine derivatives and organoselenium compounds are largely used in medicinal chemistry and drug development. This study is aimed at further investigating the antitumor mechanism of IP-Se-06 (3-((2-methoxyphenyl)selanyl)-7-methyl-2-phenylimidazol[1,2-a]pyridine), a selenylated imidazo[1,2-a]pyridine derivative in glioblastoma cells. IP-Se-06 exhibited high cytotoxicity against A172 cells (IC(50) = 1.8 μM) and selectivity for this glioblastoma cell. The IP-Se-06 compound has pharmacological properties verified in its ADMET profile, especially related to blood-brain barrier (BBB) permeability. At low concentration (1 μM), IP-Se-06 induced intracellular redox state modulation with depletion of TrxR and GSH levels as well as inhibition of NRF2 protein. IP-Se-06 also decreased mitochondrial membrane potential, induced cytochrome c release, and chromatin condensation. Furthermore, IP-Se-06 induced apoptosis by decreasing levels of Bcl-xL while increasing levels of γ-H2AX and p53 proteins. Treatment with IP-Se-06 induced cell cycle arrest and showed antiproliferative effect by inhibition of Akt/mTOR/HIF-1α and ERK 1/2 signaling pathways. In addition, IP-Se-06 displayed significant inhibition of p38 MAPK and p-p38, leading to inhibition of inflammasome complex proteins (NLRP3 and caspase-1) in glioblastoma cells. These collective findings demonstrated that IP-Se-06 is a bioactive molecule that can be considered a candidate for the development of a novel drug for glioblastoma treatment. Hindawi 2022-03-22 /pmc/articles/PMC8964227/ /pubmed/35360199 http://dx.doi.org/10.1155/2022/3710449 Text en Copyright © 2022 Daniela C. dos Santos et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
dos Santos, Daniela C.
Rafique, Jamal
Saba, Sumbal
Grinevicius, Valdelúcia M. A. S.
Filho, Danilo W.
Zamoner, Ariane
Braga, Antonio L.
Pedrosa, Rozangela C.
Ourique, Fabiana
IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title_full IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title_fullStr IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title_full_unstemmed IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title_short IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
title_sort ip-se-06, a selenylated imidazo[1,2-a]pyridine, modulates intracellular redox state and causes akt/mtor/hif-1α and mapk signaling inhibition, promoting antiproliferative effect and apoptosis in glioblastoma cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964227/
https://www.ncbi.nlm.nih.gov/pubmed/35360199
http://dx.doi.org/10.1155/2022/3710449
work_keys_str_mv AT dossantosdanielac ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT rafiquejamal ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT sabasumbal ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT grineviciusvaldeluciamas ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT filhodanilow ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT zamonerariane ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT bragaantoniol ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT pedrosarozangelac ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells
AT ouriquefabiana ipse06aselenylatedimidazo12apyridinemodulatesintracellularredoxstateandcausesaktmtorhif1aandmapksignalinginhibitionpromotingantiproliferativeeffectandapoptosisinglioblastomacells